T. Rowe Price Capital Appreciation Fund (PRWCX)
Ticker Symbol:
PRWCX
Fund Status:
Closed to new Retail investors  /  Open to subsequent Retail investments
Closed to new Retail Investors as of June 30, 2014 at 4pm EST
Fund Composition
Asset Allocation
as of 12/31/2014
Domestic Stock 58.7%
Domestic Bond 21.8%
Cash 9.1%
Foreign Bonds 6.5%
Foreign Stock 4.1%
Convertibles 0.6%
Preferreds 0.4%
Options -0.8%
Volatility and Other Measures
as of 01/31/2015
Beta 0.61
0.92
Standard Deviation 5.82
Price/Earnings Ratio (Domestic) 18.7
Earnings Growth Rate (Domestic) 11.5
Turnover Rate 6.4
Median Market
Capitalization
$31,662.79 Million
10 Largest Holdings
Represents 25.55 % of Total Net Assets
View Holdings as of:
Actavis plc
Allergan
AutoZone
Danaher
Eli Lilly
Fiserv
Intelsat Bermuda Ltd
Marsh & McLennan
Range Resources
Thermo Fisher Scientific
As of 12/31/2014 the Capital Appreciation Fund had a total of 281 holdings.
Sector Diversification
as of 01/31/2015
% of Total Net Assets
Health Care 15.7%
Financials 11.1%
Industrials & Business Services 11.0%
Consumer Discretionary 7.6%
Information Technology 7.3%
Consumer Staples 2.9%
Energy 2.6%
Utilities 2.1%
Materials 0.6%
Telecommunication Services 0.6%
See Glossary for additional details on all data elements.